| Business Name: |
Charles Harold Willingahm Md |
| Contact Person: |
Charles Harold Willingahm |
| Address: |
6739 East Calle Cadena, Tucson, Arizona 85715 |
| Phone Number: |
(520) 296-7053 |
| Annual Revenue (USD): |
$100.000 to $499.999 |
| Founding Year: |
2012 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
621111 |
| Share This Business: |
|
| Related Businesses: |
Silverman Laurance MD - Tucson, AZ 85715
Erickson Christopher MD - Tucson, AZ 85715
Mac Donald James MD - Tucson, AZ 85715
Ramakumar Sanjay MD - Tucson, AZ 85715
Purkis Michael D MD - Tucson, AZ 85715
Wiegand Christopher MD - Tucson, AZ 85715
Goeta Kreisler Kevin MD - Tucson, AZ 85715
Greenberg Jerry MD - Tucson, AZ 85715
Bacon Arthur J MD - Tucson, AZ 85715
Miller Andrea B MD - Tucson, AZ 85715
Zaetta Mark A MD - Tucson, AZ 85715
Lindner Peter J MD - Tucson, AZ 85715
Miller Melissa MD - Tucson, AZ 85715
Pina Maria MD - Tucson, AZ 85715
Pena Juan MD - Tucson, AZ 85715
Reilly Robert J MD - Tucson, AZ 85715
Posadas Maris MD - Tucson, AZ 85715
Hanks Shelli MD - Tucson, AZ 85715
Splane George MD - Tucson, AZ 85715
Schorsch John MD - Tucson, AZ 85715
|
The company Charles Harold Willingahm Md provides B2C services in the form of Doctors from its single location in Arizona.
1 to 4 employees work for Charles Harold Willingahm Md, and the business now earns $100.000 to $499.999 per annum.
Charles Harold Willingahm Md was launched in 2012 and is classified under SIC code and category 8011 , and NAICS number and grouping 621111 .
To contact Charles Harold Willingahm Md, please call Charles Harold Willingahm with the phone number (520) 296-7053 or visit its single location at 6739 East Calle Cadena in Tucson, Arizona 85715.
The location of the single location can also be found using the coordinates 32.260339,-110.848096.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.